Cryns V L, Yi S M, Tahara H, Gaz R D, Arnold A
Laboratory of Endocrine Oncology, Massachusetts General Hospital, Boston 02114, USA.
Genes Chromosomes Cancer. 1995 May;13(1):9-17. doi: 10.1002/gcc.2870130103.
Two molecular defects have been described in parathyroid adenomas: rearrangement and overexpression of the PRAD1/cyclin D1 oncogene and allelic loss of chromosome 11 DNA, often including the multiple endocrine neoplasia type 1 (MEN1) putative tumor suppressor gene region. In an effort to identify additional parathyroid tumor suppressor genes, we examined 25 parathyroid adenomas for tumor-specific allelic loss of polymorphic DNA loci located near known or candidate tumor suppressor genes. Control leukocyte DNA from all 25 patients was heterozygous for 1 or more of the 9 chromosome 1 markers examined. Allelic loss at 1 or more of these informative loci on chromosome 1 was observed in 10 of 25 (40%) adenomas. Although many tumors lost extensive regions on chromosome 1, all but one of these tumors had allelic loss of distal 1p (1p32-pter); four tumors also lost loci on 1q. Allelic loss at 11q13, the site of the MEN1 gene, was detected in 5 of 21 (24%) informative cases, including 3 with 1p loss. In contrast, allelic loss was rarely observed at loci on 9q and 10p and was not observed at loci on 3p, 3q, 4p, 5q, 12q, 14q, 18q, 22q, or Xp. In summary, clonal allelic loss of loci on chromosome arm 1p is a frequent feature of parathyroid adenomas, implying that inactivation of a tumor suppressor gene(s) on 1p commonly contributes to their pathogenesis.
PRAD1/细胞周期蛋白D1癌基因的重排和过表达,以及11号染色体DNA的等位基因缺失,其中常包括多发性内分泌腺瘤1型(MEN1)假定的肿瘤抑制基因区域。为了鉴定其他甲状旁腺肿瘤抑制基因,我们检测了25例甲状旁腺腺瘤,以寻找位于已知或候选肿瘤抑制基因附近的多态性DNA位点的肿瘤特异性等位基因缺失情况。所有25例患者的对照白细胞DNA在所检测的9个1号染色体标记中的1个或更多个上是杂合的。在25例腺瘤中的10例(40%)中观察到1号染色体上1个或更多个这些信息位点的等位基因缺失。尽管许多肿瘤在1号染色体上丢失了大片区域,但除1例肿瘤外,所有这些肿瘤均有1p远端(1p32-末端)的等位基因缺失;4例肿瘤还丢失了1q上的位点。在21例信息充分的病例中的5例(24%)中检测到MEN1基因所在位点11q13的等位基因缺失,其中3例伴有1p缺失。相比之下,在9q和10p上的位点很少观察到等位基因缺失,在3p、3q、4p、5q、12q、14q、18q、22q或Xp上的位点未观察到等位基因缺失。总之,1号染色体臂上位点的克隆性等位基因缺失是甲状旁腺腺瘤的常见特征,这意味着1p上一个或多个肿瘤抑制基因的失活通常参与了其发病机制。